Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-14-000341

Options or other derivatives

  • SVP - Novus Biologicals acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EANSOR N DAVID · SVP - Novus Biologicals

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-08-12 Grant or award : show line 1 in the form Stock Option (Right to Buy) +15,000 $94.35 2021-08-12 15,000 15,000 D
Loading xslF345X03/edgar.xml…